US Drug Recall Register
Class II · Moderate risk Terminated Initiated Apr 27, 2022 (4 years ago)

GaviLyte -C

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

Failed Stability Specification

What was recalled

GaviLyte -C (Polyethylene Glycol 3350, 240 g) and electrolytes for Oral Solution, USP with flavor pack NDC# 43386-060-19

Recalling firm
Lupin Pharmaceuticals Inc.
NDC code
43386-060-19
Origin
MD, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0875-2022

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Polyethylene recalls

See all
Class II · Moderate risk Ongoing

Artificial Tears Lubricant Eye Drops

Reason Lack of Assurance of Sterility

Preferred Pharmaceuticals, Inc. NDC 68788-7266-0 D-0443-2026
Class II · Moderate risk Ongoing

Sterile Eye Drops Soothing Tears

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 0536-1219-94 D-0415-2026
Class II · Moderate risk Ongoing

Ultra Lubricating Eye Drops

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 70000-0457-1 D-0412-2026
Class II · Moderate risk Ongoing

Dry Eye Relief Eye Drops

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 57896-181-05 D-0411-2026
Class II · Moderate risk Ongoing

EYE DROPS Advanced Relief

Reason Lack of Assurance of Sterility

K.C. Pharmaceuticals, Inc NDC 83324-191-14 D-0410-2026